down arrow

Dr Lal Pathlabs

  • Market Cap: Large Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE600L01024
  • NSEID: LALPATHLAB
  • BSEID: 539524
INR
2,675.45
8.5 (0.32%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 87.92 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

2,644.702,693.60

52 Week

2,168.803,645.00
Valuation
Technical
Day's Volume

CASH

87.92 k (-40.96%) Volume

Shareholding (Dec 2024)

FII

26.82%

Held by 327 FIIs

DII

13.17%

Held by 24 DIIs

Promoter

53.91%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 12.57% and Operating profit at 12.83% over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

With ROE of 20.1, it has a Very Expensive valuation with a 11.1 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 22,365 Cr (Large Cap)

stock-summary
P/E

53.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.90%

stock-summary
Debt Equity

-0.46

stock-summary
Return on Equity

20.05%

stock-summary
Price to Book

11.14

Revenue and Profits (1 Year):
Net Sales:
597 Cr
(Quarterly Results - Dec 2024)
Net Profit:
97 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.9%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-23.83%
0.39%
-23.44%
1 Year
16.07%
1.02%
17.09%
2 Years
43.67%
2.18%
45.85%
3 Years
-3.33%
2.34%
-0.99%
4 Years
-14.77%
2.47%
-12.3%
5 Years
81.68%
5.28%
86.96%

Latest dividend: 6 per share ex-dividend date: Feb-05-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
12.57%
EBIT Growth (5y)
12.83%
EBIT to Interest (avg)
16.81
Debt to EBITDA (avg)
0.42
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.13
Tax Ratio
28.54%
Dividend Payout Ratio
42.00%
Pledged Shares
0
Institutional Holding
39.98%
ROCE (avg)
67.57%
ROE (avg)
19.97%
Valuation key factors
Factor
Value
P/E Ratio
53
Industry P/E
55
Price to Book Value
11.14
EV to EBIT
40.38
EV to EBITDA
31.83
EV to Capital Employed
19.90
EV to Sales
8.89
PEG Ratio
2.04
Dividend Yield
0.90%
ROCE (Latest)
48.00%
ROE (Latest)
20.05%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 28 Schemes (10.25%)

FIIs

Held by 327 FIIs (26.82%)

Promoter with highest holding

Arvind Lal (30.8%)

Highest Public shareholder

Invesco Oppenheimer International Growth Fund (3.56%)

Individual Investors Holdings

4.01%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 10.73% vs 10.11% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 18.94% vs 53.98% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "596.70",
          "val2": "538.90",
          "chgp": "10.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "154.00",
          "val2": "140.60",
          "chgp": "9.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.30",
          "val2": "7.00",
          "chgp": "-24.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "96.70",
          "val2": "81.30",
          "chgp": "18.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.81%",
          "val2": "26.09%",
          "chgp": "-0.28%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 10.49% vs 10.21% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 22.77% vs 48.30% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,262.10",
          "val2": "1,142.30",
          "chgp": "10.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "372.50",
          "val2": "324.00",
          "chgp": "14.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.00",
          "val2": "15.80",
          "chgp": "-24.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "235.60",
          "val2": "191.90",
          "chgp": "22.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.51%",
          "val2": "28.36%",
          "chgp": "1.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 10.56% vs 10.18% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 21.63% vs 49.95% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,858.80",
          "val2": "1,681.20",
          "chgp": "10.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "526.50",
          "val2": "464.60",
          "chgp": "13.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "17.30",
          "val2": "22.80",
          "chgp": "-24.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "332.30",
          "val2": "273.20",
          "chgp": "21.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.32%",
          "val2": "27.64%",
          "chgp": "0.68%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 10.40% vs -3.38% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 49.73% vs -30.71% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,226.60",
          "val2": "2,016.90",
          "chgp": "10.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "609.30",
          "val2": "489.90",
          "chgp": "24.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "29.40",
          "val2": "37.50",
          "chgp": "-21.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "357.70",
          "val2": "238.90",
          "chgp": "49.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.36%",
          "val2": "24.29%",
          "chgp": "3.07%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
596.70
538.90
10.73%
Operating Profit (PBDIT) excl Other Income
154.00
140.60
9.53%
Interest
5.30
7.00
-24.29%
Exceptional Items
0.00
0.00
Consolidate Net Profit
96.70
81.30
18.94%
Operating Profit Margin (Excl OI)
25.81%
26.09%
-0.28%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 10.73% vs 10.11% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 18.94% vs 53.98% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,262.10
1,142.30
10.49%
Operating Profit (PBDIT) excl Other Income
372.50
324.00
14.97%
Interest
12.00
15.80
-24.05%
Exceptional Items
0.00
0.00
Consolidate Net Profit
235.60
191.90
22.77%
Operating Profit Margin (Excl OI)
29.51%
28.36%
1.15%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 10.49% vs 10.21% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 22.77% vs 48.30% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,858.80
1,681.20
10.56%
Operating Profit (PBDIT) excl Other Income
526.50
464.60
13.32%
Interest
17.30
22.80
-24.12%
Exceptional Items
0.00
0.00
Consolidate Net Profit
332.30
273.20
21.63%
Operating Profit Margin (Excl OI)
28.32%
27.64%
0.68%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 10.56% vs 10.18% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 21.63% vs 49.95% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
2,226.60
2,016.90
10.40%
Operating Profit (PBDIT) excl Other Income
609.30
489.90
24.37%
Interest
29.40
37.50
-21.60%
Exceptional Items
0.00
0.00
Consolidate Net Profit
357.70
238.90
49.73%
Operating Profit Margin (Excl OI)
27.36%
24.29%
3.07%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 10.40% vs -3.38% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 49.73% vs -30.71% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Dr Lal Pathlabs Ltd stock-summary
stock-summary
Dr Lal Pathlabs Ltd
Large Cap
Hospital & Healthcare Services
Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name `Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi. The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company. The Company converted into a Public Limited Company and name of the Company was changed to `Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015.
Company Coordinates stock-summary
Company Details
E-2 Block Sector 18, Rohini New Delhi New Delhi : 110085
stock-summary
Tel: 91-011-3024 4149
stock-summary
http://www.lalpathlabs.com
stock-summary
cs@lalpathlabs.com
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."